Head and neck cancer: The pursuit of molecular diagnostic markers

Seminars in Oncology

Volumn 31, Issue 6, 2004, Pages 718-725

  Hasina, Rifat ^a   Lingen, Mark W ^a  

^a Univ C

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

ADJUVANT THERAPY; CHROMOSOME ABERRATION; DEVELOPMENTAL STAGE; DIAGNOSTIC PROCEDURE; DNA METABOLISM; GENOMICS; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MOLECULAR MECHANICS; MOUTH CANCER; MOUTH LESION; NONHUMAN; PATHOLOGIST; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SQUAMOUS CELL CARCINOMA; TECHNIQUE;

EID: 10044256652     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.09.012     Document Type: Article

References (81)

1. E.E. Vokes, R.R. Weichselbaum, S.M. Lippman Head and neck cancer N Engl J Med 328 1993 184 194
2. A. Forastiere, W. Koch, A. Trotti Head and neck cancer N Engl J Med 345 2001 1890 1900
3. P. Pisani, F. Bray, D.M. Parkin Estimates of the world-wide prevalence of cancer for 25 sites in the adult population Int J Cancer 97 2002 72 81
4. E.R. Fearon, B. Volgelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
5. L. Mao, J.S. Lee, Y.H. Fan Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment Nat Med 2 1996 682 685
6. A.L. Reed, J. Califano, P. Cairns High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma Cancer Res 56 1996 3630 3633
7. V. Papadimitrakopoulou, J. Izzo, S.M. Lippman Frequent inactivation of p16INK4a in oral premalignant lesions Oncogene 14 1997 1799 1803
8. K. Okami, A.L. Reed, P. Cairns Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma Oncogene 18 1999 3541 3545
9. R. Maestro, D. Gasparotto, T. Vukosavljevic Three discrete regions of deletion at 3p in head and neck cancers Cancer Res 53 1993 5775 5779
10. J.O. Boyle, J. Hakim, W. Koch The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res 53 1993 4477 4480
11. M.P. Rosin, X. Cheng, C. Poh Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia Clin Cancer Res 6 2000 357 362
12. J.G. Izzo, V.A. Papadimitrakopoulou, X.Q. Li Dysregulated cyclin D1 expression early in head and neck tumorigenesis In vivo evidence for an association with subsequent gene amplification Oncogene 17 1998 2313 2322
13. P. Capaccio, G. Pruneri, N. Carboni Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes Head Neck 22 2000 234 240
14. R. Michalides, N. van Veelen, A. Hart Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck Cancer Res 55 1995 975 978
15. S.E. Chang, P. Bhatia, N.W. Johnson ras mutations in United Kingdom examples of oral malignancies are infrequent Int J Cancer 48 1991 409 412
16. W.A. Yeudall, L.K. Torrance, K.A. Elsegood ras pont mutation is a rare event in premalignant tissue and malignant cells and tissues from oral mucosal lesions Eur J Cancer Oral Oncol 29B 1993 63 67
17. N. Das, J. Majumder, U.B. DasGupta ras gene mutations in oral cancer in eastern India Oral Oncol 36 2000 76 80
18. D. Saranath, S.E. Chang, L.T. Bhoite High frequency mutations in codons 12 and 61 of H-ras oncogene in chewing tobacco related human oral squamous carcinoma in India Br J Cancer 63 1991 573 578
19. D.J. Haraf, E. Nodzenski, D. Brachman Human papilloma virus and p53 in head and neck cancer Clinical correlates and survival Clin Cancer Res 2 1996 755 762
20. L.G. Portugal, J.D. Goldenberg, B.L. Wenig Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma Arch Otolaryngol Head Neck Surg 123 1997 1230 1234
21. J. Penhallow, H. Steingrimsdottir, F. Elamin p53 alterations and HPV infections are common in oral SCC p53 gene mutations correlate with the absence of HPV 16-E6 DNA Int J Oncol 12 1998 59 68
22. M.L. Gillison, W.M. Koch, R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
23. T. Wiest, E. Schwarz, C. Enders Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control Oncogene 21 2002 1510 1517
24. W.M. Koch, M. Lango, D. Sewell Head and neck cancer in nonsmokers A distinct clinical and molecular entity Laryngoscope 109 1999 1544 1551
25. M.W. Lingen, E.M. Sturgis, M.S. Kies Squamous cancer of the head and neck in non-smokers Clinical and biological characteristics, and implications for therapy Curr Opin Oncol 13 2001 176 182
26. S.P. Schantz, G.P. Yu Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer Arch Otolaryngol Head Neck Surg 128 2002 268 274
27. M.W. Lingen, K.-W. Chang, H.J. Pelzer Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9 Head Neck 22 2000 328 335
28. X. Wu, S.M. Lippman, J.J. Lee Chromosome instability in lymphocytes A potential indicator of predisposition to oral premalignant lesions Cancer Res 62 2002 2813 2818
29. K.K. Yu, A.M. Zanation, J.R. Moss Familial head and neck cancer Molecular analysis of a new clinical entity Laryngoscope 112 2002 1587 1593
30. E.M. Sturgis, Q. Wei Genetic susceptibility--Molecular epidemiology of head and neck cancer Curr Opin Oncol 14 2002 310 317
31. U. Egeli, L. Ozkan, B. Tunca The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites Head Neck 22 2000 591 598
32. C. Leethanakul, V. Patel, J. Gillespie Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays Oncogene 19 2000 3220 3224
33. I. Alevizos, M. Mahadevappa, X. Zhang Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis Oncogene 20 2001 6196 6204
34. A.K. El-Naggar, H.W. Kim, G.L. Clayman Differential expression profiling of head and neck squamous carcinoma Significance in their phenotypic and biological classification Oncogene 21 2002 8206 8219
35. T.J. Belbin, B. Singh, I. Barber Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays Cancer Res 62 2002 1184 1190
36. E. Mendez, C. Cheng, D.G. Farwell Transcriptional expression profiles of oral squamous cell carcinomas Cancer 95 2002 1482 1494
37. P.K. Ha, N.E. Benoit, R. Yochem A transcriptional progression model for head and neck cancer Clin Cancer Res 9 2003 3058 3064
38. K. Yanagisawa, Y. Shyr, B.J. Xu Proteomic patterns of tumour subsets in non-small-cell lung cancer Lancet 362 2003 433 439
39. M.V. Dwek, A.A. Alaiya Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues Br J Cancer 89 2003 305 307
40. J.D. Wulfkuhle, L.A. Liotta, E.F. Petricoin Proteomic applications for the early detection of cancer. Nature reviews Cancer 3 2003 267 275
41. G.C. Adam, E.J. Sorensen, B.F. Cravatt Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype Nat Biotechnol 20 2002 805 809
42. J.D. Wulfkuhle, D.C. Sgroi, H. Krutzsch Proteomics of human breast ductal carcinoma in situ Cancer Res 62 2002 6740 6749
43. C. Melle, G. Ernst, B. Schimmel Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry Mol Cell Proteomics 2 2003 443 452
44. S. Silverman Early diagnosis of oral cancer Cancer 62 1988 1796 1799
45. D.C. Shugars, L.L. Patton Detecting, diagnosing, and preventing oral cancer Nurse Pract 22 1997 109 115
46. J.D. Whited, J.M. Grichnick Does this patient have a mole or a melanoma? JAMA 279 1998 696 701
47. F.H. Rampen, J.I. Casparie-van Velsen, B.E. van Huystee False-negative findings in skin cancer and melanoma screening J Am Acad Dermatol 33 1995 59 63
48. A. Mashberg, L.J. Feldman Clinical criteria for identifying early oral and oropharyngeal carcinoma Erythroplasia revisted Am J Surg 156 1988 273 275
49. H. Sandler Cytological screening for early mouth cancer Cancer 15 1962 1119 1124
50. G. Anneroth, J. Batsakis, M. Luna Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas Scand J Dent Res 95 1987 229 249
51. L.M. Abbey, G.E. Kaugars, J.C. Gunsolley Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia Oral Surg Oral Med Oral Path Oral Radiat Endod 80 1995 188 191
52. H.C. De Vet, J. Koudstaal, W.S. Kwee Efforts to improve interobserver agreement in histopathological grading J Clin Epidemiol 48 1995 869 873
53. A. Karabulut, J. Reibel, M.H. Therkildsen Observer variability in the histologic assessment of oral premalignant lesions J Oral Pathol Med 24 1995 198 200
54. P.J. Polverini, D.B. Solt Expression of the angiogenic phenotype by a subpopulation of keratinocytes from 7,12-dimethylbenz(a)anthracene-initiated hamster pouch epithelium Carcinogenesis 9 1988 117 122
55. J.R. Morocco, D.B. Solt, P.J. Polverini Sequential loss of tumor suppressor genes for three specific functions during in vivo carcinogenesis Lab Invest 63 1990 298 306
56. M.W. Lingen, L.A. DiPietro, D.B. Solt H-ras stimulates anchorage independence but not TGFβ mediated angiogenesis in keratinocytes cultured from the in vivo hamster buccal pouch model of oral carcinogenesis Carcinogenesis 18 1997 329 338
57. J. Sudbo, T. Ried, M. Bryne Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches Oral Oncol 37 2001 558 565
58. J.J. Lee, W.K. Hong, W.N. Hittelman Predicting cancer development in oral leukoplakia Ten years of translational research Clin Cancer Res 6 2000 1702 1710
59. Z. Guo, K. Yamaguchi, M. Sanchez-Cespedes Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy Clin Cancer Res 7 2001 1963 1968
60. J.S. Lee, S.Y. Kim, W.K. Hong Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion J Natl Cancer Inst 85 1993 1951 1954
61. H.H. Mincer, S.A. Coleman, K.P. Hopkins Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia Oral Surg 33 1972 389 399
62. J.W. Evenson Oral remalignancy Cancer Surv 2 1983 403 424
63. J. Sudbo, W. Kildal, B. Risberg DNA content as a prognostic marker in patients with oral leukoplakia N Engl J Med 344 2001 1270 1278
64. J. Sudbo, W. Kildal, A.C. Johannessen Gross genomic aberrations in precancers Clinical implications of a long-term follow-up study in oral erythroplakias J Clin Oncol 20 2002 456 462
65. J.A. Brennan, L. Mao, R.H. Hruban Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck N Engl J Med 332 1995 429 435
66. S.A. Ahrendt, Y. Hu, M. Buta p53 mutations and survival in stage I non-small-cell lung cancer Results of a prospective study J Natl Cancer Inst 95 2003 961 970
67. F.P. Wikman, M.L. Lu, T. Thykjaer Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples Clin Chem 46 2000 1555 1561
68. W.H. Wen, L. Bernstein, J. Lescallett Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis Cancer Res 60 2000 2716 2722
69. S.A. Ahrendt, S. Halachmi, J.T. Chow Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array Proc Natl Acad Sci U S A 96 1999 7382 7387
70. C.A. Nathan, N. Amirghahri, C. Rice Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients Laryngoscope 112 2002 2129 2140
71. L. Zhang, C.F. Poh, W.L. Lam Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia Molecular evidence of incomplete resection Oral Oncol 37 2001 505 512
72. M. Partridge, S.R. Li, S. Pateromichelakis Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment Clin Cancer Res 6 2000 2718 2725
73. J. Califano, W.H. Westra, W. Koch Unknown primary head and neck squamous cell carcinoma Molecular identification of the site of origin J Natl Cancer Inst 91 1999 599 604
74. E.J. Nieuwenhuis, C.R. Leemans, A. Kummer Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction Lab Invest 83 2003 1233 1240
75. E.J. Nieuwenhuis, L.H. Jaspars, J.A. Castelijns Institution quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates Clin Cancer Res 9 2003 755 761
76. W.M. Koch, J.A. Brennan, M. Zahurak p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma J Natl Cancer Inst 88 1996 1580 1586
77. C.R. Bradford, S. Zhu, H. Ogawa p53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines Head Neck 25 2003 654 661
78. D. Bergamaschi, M. Gasco, L. Hiller p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Cancer Cell 3 2003 387 402
79. R. Hasina, K. Hulett, S. Bicciato Plasminogen activator inhibitor-2 A molecular biomarker for head and neck cancer progression Cancer Res 63 2003 555 559
80. M.F. Spafford, W.M. Koch, A.L. Reed Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis Clin Cancer Res 7 2001 607 612
81. H. Nawroz, W. Koch, P. Anker Microsatellite alterations in serum DNA of head and neck cancer patients Nat Med 2 1996 1035 1037